At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Feb 26, 2026 at 19:00 ET
Krystal Biotech CEO Krishnan Krish and Chief Accounting Officer Kathryn Romano sold shares in the open market, totaling $324,982 in proceeds over the past week. These were open-market sales by two executives, with the CEO selling 483 shares and the CAO selling 750 shares at prices between $257 and $268.
- CEO Krishnan Krish sold 483 shares at $257.31, totaling $124,282 in open-market transaction on March 4, 2026.
- Chief Accounting Officer Kathryn Romano sold 750 shares at $267.60, totaling $200,700 in open-market transaction on March 2, 2026.
- Total open-market sales by insiders in the past 7 days: $324,982.
- Sales represent approximately 0.0043% of Krystal Biotech's $7.6B market cap, well below the 0.1% threshold for materiality.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access